The variability in estrogenic activation results for compounds in the Luciferase assay may be due to dose-response relationships, cell line variability, assay limitations, and biological variation. To enhance reliability, use multiple cell lines, validate with controls, and consider alternative assays. Ensure compound stability, avoid contaminants, and account for time-dependent and cross-reactive effects.